Arkansas 2025 Regular Session

Arkansas House Bill HB1262

Introduced
1/27/25  
Refer
1/27/25  
Report Pass
2/6/25  
Engrossed
2/10/25  
Enrolled
2/11/25  
Chaptered
2/13/25  

Caption

An Act For The Arkansas State University - Arkansas Biosciences Institute Appropriation For The 2025-2026 Fiscal Year.

Impact

The bill establishes a framework for funding operations through the Tobacco Settlement Program Fund, allocating a total amount of approximately $5.6 million. This funding is critical as it supports not only the academic staff positions but also other operational activities of the institute, ensuring it has the resources necessary to conduct its research and educational programs. The provision for transfer restrictions means that funds can only be reallocated under strict oversight, promoting accountability in the use of state resources.

Summary

House Bill 1262 is an appropriation bill aimed at funding personal services and operational expenses for the Arkansas State University - Arkansas Biosciences Institute for the fiscal year ending June 30, 2026. The bill outlines specific budgetary allocations for regular salaries, hiring of faculty, and operational costs necessary for the institute's functions. This initiative reflects the General Assembly's commitment to maintaining the operational viability of the institute, which plays a pivotal role in research and educational endeavors in the state.

Sentiment

The sentiment surrounding HB 1262 appears to be generally supportive, given the importance of funding for educational institutions in fostering research and development in the state. Proponents argue that investment in the Arkansas Biosciences Institute is essential for economic growth and innovation, especially in the biosciences sector. However, concerns may arise over the sustainability of funding from the Tobacco Settlement, especially if these funds are insufficient for future needs, which could affect staff and program continuity.

Contention

A notable point of contention is the dependency on Tobacco Settlement funds, which raises questions about the long-term viability of such funding sources. Critics might argue that relying on a limited funding source limits the financial flexibility of the institute and poses risks if those funds dwindle. Additionally, the oversight requirements concerning budget transfers may raise concerns about bureaucratic inefficiencies, although supporters argue it is necessary for ensuring taxpayer money is spent wisely.

Companion Bills

No companion bills found.

Similar Bills

AR HB1267

An Act For The Uams - Reynolds Center On Aging, Boozman College Of Public Health, Ark. Biosciences Institute, & The Area Health Ed. Center In Helena Appropriation For The 2025-2026 Fiscal Year.

AR HB1259

An Act For The University Of Arkansas And The Division Of Agriculture - Arkansas Biosciences Institutes Appropriation For The 2025-2026 Fiscal Year.

NM SB119

Investment In Bioscience Companies

ND SB2311

The bioscience innovation grant program.

NM HB20

Technology & Innovation Division

TX HR835

Recognizing March 29, 2023, as Vaccine Awareness and Advocacy Day at the State Capitol and commending the work of the Baker Institute for Public Policy Center for Health and Biosciences at Rice University.

TX HB2630

Relating to the formal recognition and administration of The Texas A&M University System Health Science Center.

NM SB107

Nmsu Stem Center Of Excellence